Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,505.00
-12.00 (-0.48%)
Jul 31, 2026, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 412.37 billion as of July 31, 2026. Its market cap has increased by 21.46% in one year.
Market Cap
412.37B
Enterprise Value
381.61B
Revenue
64.31B
Ranking
n/a
PE Ratio
40.19
Stock Price
2,505.00
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 412.37B, an increase of 38.80%. That is a compound annual growth rate of 5.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 412.37B | 45.35% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 961.65B |
| Aurobindo Pharma | 906.97B |
| Alkem Laboratories | 695.45B |
| Glenmark Pharmaceuticals | 618.10B |
| Ipca Laboratories | 446.21B |
| Ajanta Pharma | 429.16B |
| Emcure Pharmaceuticals | 362.29B |
| Wockhardt | 309.39B |